Michael Hearne Stock Transaction

Michael Hearne, Chief Financial Officer of Aurinia Pharmaceuticals Inc., reported a stock transaction on May 18, 2026. He acquired 116,144 shares of Common Stock with a transaction price of $0.00. Additionally, he acquired an Employee Stock Option (right to buy) for 70,230 shares of Common Stock, with an exercise price of $15.28. This transaction is categorized as an Officer/Director transaction.